Product Name:Shikimic acid 98.0%
Botanical Source:Star Anise Extract
Latin Name:Illicium verum Hook .f
Part: Seed(Dried, 100% Natural)
Extraction Method: Water/ Grain Alcohol
Form: white powder
Specification: 95%-99%
Test Method : HPLC
CAS NO.: 138-59-0
Molecular Formula: C7H10O5
Molecular Weight:174.15
GMO Status:GMO Free
Packing: in 25kgs fiber drums
Storage:Keep container unopened in cool, dry place,Keep away from strong light
Shelf Life:24 months from date of production
Shikimic Acid 98.0%: High-Purity Intermediate for Pharmaceutical and Industrial Applications
Product Overview
Shikimic Acid (CAS 138-59-0) is a naturally occurring chiral compound, widely recognized as a critical intermediate in the biosynthesis of aromatic amino acids and pharmaceutical agents. With a purity of ≥98.0% (HPLC verified), our product meets stringent quality standards for research, pharmaceutical synthesis, and industrial applications. Derived from advanced microbial fermentation technology, it offers a sustainable and cost-effective alternative to traditional plant extraction methods .
Key Features
- High Purity: ≥98.0% (HPLC validated), ensuring reliability for sensitive applications like drug formulation .
- Versatile Solubility: Soluble in ethanol (2.5 mg/ml), DMSO (25 mg/ml), and PBS (10 mg/ml at pH 7.2). Aqueous solutions are stable for 24 hours .
- Long-Term Stability: Stable for ≥4 years when stored at -20°C in crystalline form .
- Sustainable Production: Produced via genetically engineered Bacillus subtilis strains, optimizing yield (up to 87 g/L) and reducing environmental impact .
Applications
- Pharmaceuticals:
- Antiviral Drug Synthesis: Key precursor for Oseltamivir (Tamiflu®), a frontline treatment for influenza A/B and swine/avian flu .
- Anti-Inflammatory & Antioxidant: Reduces oxidative stress in colitis models (40–80 µM) and inhibits pro-inflammatory cytokines .
- Osteoporosis Therapy: Suppresses RANK/TRAF6 interaction, mitigating bone loss in ovariectomized mice (50–200 mg/kg) .
- Cosmetics:
- Skin Whitening: Inhibits tyrosinase activity, reducing melanin formation for hyperpigmentation treatment .
- Anti-Aging Formulations: Enhances exfoliation and antioxidant protection in premium skincare products .
- Biomedical Research:
- Metabolic pathway studies (e.g., aromatic amino acid biosynthesis) .
- Ligand binding assays and cytotoxicity screening .
Technical Specifications
| Parameter | Details |
|---|---|
| Molecular Formula | C₇H₁₀O₅ |
| Molecular Weight | 174.2 g/mol |
| Purity | ≥98.0% (HPLC) |
| Appearance | White to off-white crystalline solid |
| Storage | -20°C in airtight container |
| Stability | ≥4 years |
| Safety | For research use only. Not for human consumption. |
Market Advantage
- High Demand: Global market growth driven by pharmaceutical needs (e.g., Tamiflu® production) and cosmetic innovations .
- Price Stability: Fermentation-based production mitigates supply chain risks from plant-derived shortages .
- Regulatory Compliance: Meets USP/EP standards for pharmaceutical-grade ingredients .
Why Choose Us?
- Quality Assurance: Batch-specific HPLC reports and ISO-certified manufacturing .
- Scalable Supply: Capable of bulk production (up to 14L bioreactor scale) with rapid delivery .
- Technical Support: Dedicated team for application guidance and custom synthesis inquiries.
Keywords
Shikimic Acid 98%, High Purity Shikimic Acid, Tamiflu Precursor, Anti-Inflammatory Compound, Skin Whitening Agent, Microbial Fermentation, Pharmaceutical Intermediate, Osteoporosis Research.
